Background
Methods
Study design and study subjects
Data and definitions
Statistical analysis
Results
Baseline characteristics
Characteristics | N = 183 |
---|---|
Male sex | 74 (40.4) |
Age at diagnosis, years | 63.1 ± 12.7 |
BMI, kg/m2 | 20.0 ± 3 |
Diabetes mellitus | 25 (13.7) |
Hypertension | 47 (25.7) |
Antiplatelet or anti-coagulation | 21 (11.5) |
History of pulmonary tuberculosis | 65 (35.5) |
Hemoptysis | 78 (42.6) |
Occurrence of bronchial artery embolization | 33 (18.0) |
Surgical management of hemoptysis | 0 (0) |
Radiologic finding of NTM lung diseases | |
Nodular bronchiectatic | 155 (84.7) |
≤ 3 lobes | 113 (61.7) |
> 3 lobes | 42 (23.0) |
Fibrocavitary | 28 (15.3) |
≤ 3 lobes | 12 (6.6) |
> 3 lobes | 16 (8.7) |
Distribution of chest CT | |
≤ 3 lobes | 125 (68.3) |
> 3 lobes | 58 (31.7) |
Follow up duration, months | 48.7 ± 37.8 |
NTM species identified from pulmonary specimens | |
M. avium | 59 (32.2) |
M. intracellulare | 64 (35.0) |
M. abscessus | 40 (21.9) |
M. kansasii | 6 (3.3) |
M. fortuitum | 2 (1.1) |
M. heckeshornense | 1(0.5) |
M. szulgai | 1(0.5) |
M. avium + M. intracellulare | 2 (1.1) |
M. avium + M abscessus | 4 (2.2) |
M. intracellulare + M. abscessus | 3 (1.6) |
M. abscessus + M. tuberculosis | 1 (0.5) |
Comparison of groups
Univariate | Multivariate | |||
---|---|---|---|---|
Without hemoptysis (n = 105) | With hemoptysis (n = 78) | P-value |
OR (95% CI)
| |
Male sex | 47 (44.8) | 27 (34.6) | 0.167 | 1.211 (0.632–2.321) |
Age, years, at diagnosis | 65.7 ± 12.8 | 59.7 ± 11.8 | 0.002 | 0.969 (0.943–0.996) |
BMI, kg/m2 | 20.0 ± 3.3 | 20.2 ± 2.7 | 0.758 | |
Diabetes mellitus | 19 (18.1) | 6 (7.7) | 0.043 | 0.508 (0.179–1.441) |
Hypertension | 32 (30.5) | 15 (19.2) | 0.085 | 0.870 (0.398–1.903) |
Follow-up duration, months | 48.3 ± 36.1 | 49.2 ± 37.9 | 0.864 | |
Performed bronchoscopy | 45 (42.9) | 52 (66.7) | 0.002 | |
Type of chest CT | ||||
Nodular bronchiectatic | 89 (84.8) | 66 (84.6) | 0.978 | |
Fibrocavitary | 16 (15.2) | 12 (15.4) | ||
Distribution of chest CT | ||||
≤ 3 lobes | 67 (64.4) | 58 (74.4) | 0.129 | |
> 3 lobes | 38 (36.2) | 20 (25.6) | ||
Antiplatelet/anticoagulation therapy | 11(10.5) | 10 (12.8) | 0.646 | |
Liver disease | 7 (6.7) | 9 (11.5) | 0.080 | 1.117 (0.668–1.869) |
History of pulmonary tuberculosis | 34 (32.4) | 31 (39.7) | 0.303 | 1.366 (0.726–2.572) |
Charlson Comorbidity Index score | 1.5 ± 1.8 | 1.3 ± 1.6 | 0.315 | |
NTM species identified | ||||
M. avium | 31 (29.5) | 28 (35.9) | 0.181 | |
M. intracellulare | 44 (41.9) | 20 (25.6) | ||
M. abscessus | 20 (19.0) | 20 (25.6) | ||
M. kansasii | 4 (3.8) | 2 (2.6) | ||
M. fortuitum | 1 (1.0) | 1(1.3) | ||
M. heckeshornense | 0 | 1(1.3) | ||
M. szulgai | 0 | 1(1.3) | ||
M. avium + M. intracellulare | 0 | 2(2.6) | ||
M. avium + M. abscessus | 3 (2.9) | 1 (1.3) | ||
M. intracellulare + M. abscessus | 1 (1) | 2 (2.6) | ||
M. abscessus + M. tuberculosis | 1(1) | 0 |
Analysis of group with hemoptysis
Medical (n = 45) | BAE (n = 33) | P-value | |
---|---|---|---|
Male sex | 12 (26.7) | 15 (45.5) | 0.098 |
Age, years, at diagnosis | 59.5 ± 11.7 | 60.0 ± 12.1 | 0.855 |
BMI, kg/m2 | 20.5 ± 2.6 | 19.8 ± 2.9 | 0.274 |
Diabetes mellitus | 2 (4.4) | 4 (12.1) | 0.392 |
Hypertension | 8 (17.8) | 7 (21.2) | 0.704 |
Performed bronchoscopy | 28 (62.2) | 24 (72.7) | 0.466 |
Type of chest CT | |||
Nodular bronchiectatic | 38 (84.4) | 28 (84.8) | 0.961 |
Fibrocavitary | 7 (15.6) | 5 (15.2) | |
> 3 lobe distribution of chest CT | 8 (17.8) | 12 (36.4) | 0.073 |
Antiplatelet/anticoagulation therapy | 5 (11.1) | 5 (15.2) | 0.735 |
Liver disease | 4 (8.9) | 5 (15.2) | 0.726 |
History of pulmonary tuberculosis | 15 (33.3) | 16 (48.5) | 0.242 |
Charlson Comorbidity Index score | 1.04 ± 1.1 | 1.6 ± 2.0 | 0.119 |
2 NTM pathogens identified | 4 (8.9) | 1 (3.0) | 0.389 |
Complication after BAE | 0 | ||
Repeat BAE due to rebleeding | 8 (24.2) | ||
Duration between first BAE and rebleedinga | 10 (7.5–53.5)a | ||
Number of BAE trials | |||
1 | 25 (75.8) | ||
2 | 5 (15.2) | ||
5 | 2 (6.1) | ||
8 | 1 (3.0) |
Number | NTM pathogen | Interval to recurrence | Number of BAEs | Radiological type on chest CT | Distribution of chest CT | History of pulmonary TB | Antiplatelet/ Anticoagulation | CCI score |
---|---|---|---|---|---|---|---|---|
BAE group | ||||||||
Case 1 |
M. abscessus
| 63 months | 2 | Fibrocavitary | > 3 lobes | Yes | No | 1 |
Case 2 |
M. abscessus
| 8 months | 8 | Nodular bronchiectatic | > 3 lobes | No | No | 2 |
Case 3 |
M. intracellulare
| 28 months | 2 | Nodular bronchiectatic | ≤ 3 lobes | Yes | Yes | 1 |
Case 4 |
M. abscessus
| 8 months | 5 | Nodular bronchiectatic | > 3 lobes | Yes | No | 1 |
Case 5 |
M. intracellulare
| 3 months | 5 | Nodular bronchiectatic | ≤ 3 lobes | Yes | No | 1 |
Case 6 |
M. avium
| 62 months | 2 | Nodular bronchiectatic | ≤ 3 lobes | No | No | 0 |
Case 7 |
M. abscessus
| 7 months | 2 | Nodular bronchiectatic | ≤ 3 lobes | No | Yes | 2 |
Case 8 |
M. abscessus
| 12 months | 2 | Nodular bronchiectatic | > 3 lobes | No | No | 2 |
Medical group | ||||||||
Case 1 |
M. abscessus
| 47 months | Nodular bronchiectatic | ≤ 3 lobes | No | No | 2 | |
Case 2 |
M. abscessus
| 70 months | Nodular bronchiectatic | ≤ 3 lobes | No | No | 1 | |
Case 3 |
M. avium
| 9 months | Nodular bronchiectatic | > 3 lobes | No | No | 3 | |
Case 4 |
M. avium
| 2 months | Nodular bronchiectatic | ≤ 3 lobes | No | No | 0 | |
Case 5 |
M. avium
| 88 months | Nodular bronchiectatic | ≤ 3 lobes | No | No | 0 | |
Case 6 |
M. avium
| 66 months | Nodular bronchiectatic | ≤ 3 lobes | No | No | 2 | |
Case 7 |
M. avium
| 133 months | Nodular bronchiectatic | ≤ 3 lobes | Yes | No | 0 | |
Case 8 |
M. avium
| 75 months | Nodular bronchiectatic | ≤ 3 lobes | Yes | No | 1 | |
Case 9 |
M. intracellulare
| 59 months | Nodular bronchiectatic | ≤ 3 lobes | Yes | No | 4 | |
Case 10 |
M. intracellulare
| 4 months | Nodular bronchiectatic | ≤ 3 lobes | No | Yes | 2 | |
Case 11 |
M. abscessus
| 19 months | Nodular bronchiectatic | ≤ 3 lobes | No | No | 3 | |
Case 12 |
M. avium
| 2 months | Fibrocavitary | ≤ 3 lobes | No | No | 2 |